Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · IEX Real-Time Price · USD
15.66
-1.02 (-6.12%)
At close: Apr 18, 2024, 4:00 PM
15.63
-0.03 (-0.19%)
Pre-market: Apr 19, 2024, 4:30 AM EDT
Tourmaline Bio Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Tourmaline Bio stock have an average target of 61.8, with a low estimate of 48 and a high estimate of 74. The average target predicts an increase of 294.64% from the current stock price of 15.66.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Tourmaline Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +372.54% | Mar 25, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $41 → $72 | Strong Buy | Maintains | $41 → $72 | +359.77% | Mar 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +206.51% | Mar 20, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $41 | Strong Buy | Initiates | $41 | +161.81% | Dec 15, 2023 |
| Truist Securities | Truist Securities | Strong Buy Initiates $43 | Strong Buy | Initiates | $43 | +174.58% | Nov 17, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
12.24M
EPS This Year
-2.93
from -8.87
EPS Next Year
-3.07
from -2.93
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | 63.0M | 63.0M |
| Avg | n/a | 12.2M | 12.2M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 414.7% |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.29 | -0.65 | -1.59 |
| Avg | -2.93 | -3.07 | -3.52 |
| Low | -3.78 | -4.73 | -4.61 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.